| Date Filed | Type | Description |
| 07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/18/2023 |
4
| Campbell Chad Thomas (SVP/GM, Vascular Access) has filed a Form 4 on ANGIODYNAMICS INC|
Txns:
| Paid exercise price by delivering 596 shares
@ $9.63, valued at
$5.7k
Paid exercise price by delivering 279 shares
@ $9.56, valued at
$2.7k
|
|
| 07/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/30/2021 |
4/A
| Campbell Chad Thomas (SVP/GM, Vascular Access) has filed a Form 4 on ANGIODYNAMICS INC|
Txns:
| Granted 11,923 options to buy
@ $26.49, valued at
$315.8k
|
|
| 10/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 08/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/27/2021 |
4
| Campbell Chad Thomas (SVP/GM, Vascular Access) has filed a Form 4 on ANGIODYNAMICS INC|
Txns:
| Paid exercise price by delivering 318 shares
@ $26.1, valued at
$8.3k
|
|
| 07/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/28/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2020 |
4
| Campbell Chad Thomas (SVP/GM, Vascular Access) has filed a Form 4 on ANGIODYNAMICS INC|
Txns:
| Paid exercise price by delivering 826 shares
@ $11.21, valued at
$9.3k
|
|
| 10/18/2019 |
4
| Campbell Chad Thomas (SVP/GM, Vascular Access) has filed a Form 4 on ANGIODYNAMICS INC|
Txns:
| Granted 6,195 options to buy
@ $0 |
|
| 08/19/2019 |
4
| Campbell Chad Thomas (SVP/GM, Vascular Access) has filed a Form 4 on ANGIODYNAMICS INC|
Txns:
| Paid exercise price by delivering 1,050 shares
@ $21.68, valued at
$22.8k
Exercised 6,103 options to buy
@ $0 |
|
| 08/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/25/2019 |
4
| Campbell Chad Thomas (SVP/GM, Vascular Access) has filed a Form 4 on ANGIODYNAMICS INC|
Txns:
| Paid exercise price by delivering 218 shares
@ $21.53, valued at
$4.7k
Paid exercise price by delivering 74 shares
@ $21.53, valued at
$1.6k
|
|
| 07/19/2019 |
4
| Campbell Chad Thomas (SVP/GM, Vascular Access) has filed a Form 4 on ANGIODYNAMICS INC|
Txns:
| Granted 3,098 shares
@ $0
Granted 10,361 options to buy
@ $21.54, valued at
$223.2k
|
|
| 05/24/2019 |
4
| Campbell Chad Thomas (SVP/GM, Vascular Access) has filed a Form 4 on ANGIODYNAMICS INC|
Txns:
| Paid exercise price by delivering 858 shares
@ $19.15, valued at
$16.4k
|
|
| 07/30/2018 |
4
| Campbell Chad Thomas (SVP/GM, Vascular Access) has filed a Form 4 on ANGIODYNAMICS INC|
Txns:
| Paid exercise price by delivering 252 shares
@ $21.42, valued at
$5.4k
|
|
| 07/27/2018 |
4
| Campbell Chad Thomas (SVP/GM, Vascular Access) has filed a Form 4 on ANGIODYNAMICS INC|
Txns:
| Paid exercise price by delivering 276 shares
@ $21.88, valued at
$6k
|
|
| 07/20/2018 |
4
| Campbell Chad Thomas (SVP/GM, Vascular Access) has filed a Form 4 on ANGIODYNAMICS INC|
Txns:
| Granted 3,539 shares
@ $0
Granted 11,276 options to buy
@ $20.93, valued at
$236k
Granted 7,079 options to buy
@ $0 |
|
| 05/24/2018 |
4
| Campbell Chad Thomas (SVP/GM, Vascular Access) has filed a Form 4 on ANGIODYNAMICS INC|
Txns:
| Paid exercise price by delivering 827 shares
@ $20.37, valued at
$16.8k
|
|
| 07/28/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/25/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/25/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |